{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T05:48:24Z","timestamp":1744436904995},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T00:00:00Z","timestamp":1382745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12253-013-9709-y","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T17:45:43Z","timestamp":1382723143000},"page":"399-407","source":"Crossref","is-referenced-by-count":7,"title":["Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes"],"prefix":"10.1007","volume":"20","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morito","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Abe-Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiroh","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kirimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,26]]},"reference":[{"key":"9709_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2005.06.021","volume":"32","author":"JM Bennett","year":"2005","unstructured":"Bennett JM (2005) A comparative review of classification systems in myelodysplastic syndromes (MDS). Semin Oncol 32:S3\u2013S10","journal-title":"Semin Oncol"},{"key":"9709_CR2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC PRESS, Lyon"},{"key":"9709_CR3","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/sj.leu.2403180","volume":"17","author":"M Benesch","year":"2003","unstructured":"Benesch M, Platzbecker U, Ward J, Deeg HJ, Leisenring W (2003) Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis. Leukemia 17:2460\u20132466","journal-title":"Leukemia"},{"key":"9709_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0002-9440(10)62277-8","volume":"166","author":"D Campioni","year":"2005","unstructured":"Campioni D, Secchiero P, Corallini F, Melloni E, Capitani S, Lanza F, Zauli G (2005) Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am J Pathol 166:557\u2013563","journal-title":"Am J Pathol"},{"key":"9709_CR5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V99.5.1594","volume":"99","author":"YE Claessens","year":"2002","unstructured":"Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S, Lacombe C, Dreyfus F, Mayeux P, Fontenay-Roupie M (2002) In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood 99:1594\u20131601","journal-title":"Blood"},{"key":"9709_CR6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.leu.2400980","volume":"12","author":"M Kitagawa","year":"1998","unstructured":"Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R (1998) Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia 12:486\u2013492","journal-title":"Leukemia"},{"key":"9709_CR7","first-page":"3716","volume":"95","author":"L Zamai","year":"2000","unstructured":"Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES, Guidotti L, Vitale M, Zauli G (2000) TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95:3716\u20133724","journal-title":"Blood"},{"key":"9709_CR8","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V98.10.3058","volume":"98","author":"DY Zang","year":"2001","unstructured":"Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ (2001) Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 98:3058\u20133065","journal-title":"Blood"},{"key":"9709_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0046-8177(93)90082-R","volume":"24","author":"M Kitagawa","year":"1993","unstructured":"Kitagawa M, Kamiyama R, Kasuga T (1993) Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol 24:359\u2013363","journal-title":"Hum Pathol"},{"key":"9709_CR10","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","volume":"11","author":"M Kitagawa","year":"1997","unstructured":"Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa T, Kamiyama R, Hirokawa K (1997) Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 11:2049\u20132054","journal-title":"Leukemia"},{"key":"9709_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268","volume":"86","author":"A Raza","year":"1995","unstructured":"Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268\u2013276","journal-title":"Blood"},{"key":"9709_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0145-2126(02)00095-4","volume":"27","author":"M Sawanobori","year":"2003","unstructured":"Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, Hirokawa K, Kitagawa M (2003) Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk Res 27:583\u2013591","journal-title":"Leuk Res"},{"key":"9709_CR13","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1158\/0008-5472.CAN-04-4555","volume":"65","author":"E Katsoulidis","year":"2005","unstructured":"Katsoulidis E, Li Y, Yoon P, Sassano A, Altman J, Kannan-Thulasiraman P, Balasubramanian L, Parmar S, Varga J, Tallman MS, Verma A, Platanias LC (2005) Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res 65:9029\u20139037","journal-title":"Cancer Res"},{"key":"9709_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","volume":"130","author":"MR Junttila","year":"2007","unstructured":"Junttila MR, Puustinen P, Niemel\u00e4 M, Ahola R, Arnold H, B\u00f6ttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Gr\u00e8nman R, Kast J, Kallunki T, Sears R, K\u00e4h\u00e4ri VM, Westermarck J (2007) CIP2A inhibits PP2A in human malignancies. Cell 130:51\u201362","journal-title":"Cell"},{"key":"9709_CR15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4161\/cc.7.5.5492","volume":"7","author":"MR Junttila","year":"2008","unstructured":"Junttila MR, Westermarck J (2008) Mechanisms of MYC stabilization in human malignancies. Cell Cycle 7:592\u2013596","journal-title":"Cell Cycle"},{"key":"9709_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2007.06.034","volume":"130","author":"M Mumby","year":"2007","unstructured":"Mumby M (2007) PP2A: unveiling a reluctant tumor suppressor. Cell 130:21\u201324","journal-title":"Cell"},{"key":"9709_CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jnci\/djp103","volume":"101","author":"A Khanna","year":"2009","unstructured":"Khanna A, B\u00f6ckelman C, Hemmes A, Junttila MR, Wiksten JP, Lundin M, Junnila S, Murphy DJ, Evan GI, Haglund C, Westermarck J, Ristim\u00e4ki A (2009) MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 101:793\u2013805","journal-title":"J Natl Cancer Inst"},{"key":"9709_CR18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bjc.2011.346","volume":"105","author":"C B\u00f6ckelman","year":"2011","unstructured":"B\u00f6ckelman C, Lassus H, Hemmes A, Leminen A, Westermarck J, Haglund C, B\u00fctzow R, Ristim\u00e4ki A (2011) Prognostic role of CIP2A expression in serous ovarian cancer. Br J Cancer 105:989\u2013995","journal-title":"Br J Cancer"},{"key":"9709_CR19","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1158\/1078-0432.CCR-08-3283","volume":"15","author":"C C\u00f4me","year":"2009","unstructured":"C\u00f4me C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Th\u00e9zenas S, Westermarck J (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15:5092\u20135100","journal-title":"Clin Cancer Res"},{"key":"9709_CR20","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1182\/blood-2010-08-304477","volume":"117","author":"CM Lucas","year":"2011","unstructured":"Lucas CM, Harris RJ, Giannoudis A, Copland M, Slupsky JR, Clark RE (2011) Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 117:6660\u20136668","journal-title":"Blood"},{"key":"9709_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2010.294","volume":"25","author":"I Crist\u00f3bal","year":"2011","unstructured":"Crist\u00f3bal I, Garcia-Orti L, Cirauqui C, Alonso MM, Calasanz MJ, Odero MD (2011) PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia 25:606\u2013614","journal-title":"Leukemia"},{"key":"9709_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.leukres.2004.03.020","volume":"28","author":"K Yamamoto","year":"2004","unstructured":"Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M, Kurata M, Hirokawa K, Kitagawa M (2004) Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res 28:1203\u20131211","journal-title":"Leuk Res"},{"key":"9709_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"9709_CR24","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1038\/sj.onc.1209038","volume":"24","author":"JD Arroyo","year":"2005","unstructured":"Arroyo JD, Hahn WC (2005) Involvement of PP2A in viral and cellular transformation. Oncogene 24:7746\u20137755","journal-title":"Oncogene"},{"key":"9709_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gde.2004.12.004","volume":"15","author":"V Janssens","year":"2005","unstructured":"Janssens V, Goris J, Van Hoof C (2005) PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15:34\u201341","journal-title":"Curr Opin Genet Dev"},{"key":"9709_CR26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.CAN-10-1032","volume":"71","author":"X Wang","year":"2011","unstructured":"Wang X, Cunningham M, Zhang X, Tokarz S, Laraway B, Troxell M, Sears RC (2011) Phosphorylation regulates c-Myc\u2019s oncogenic activity in the mammary gland. Cancer Res 71:925\u2013936","journal-title":"Cancer Res"},{"key":"9709_CR27","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1038\/onc.2011.599","volume":"31","author":"M Niemel\u00e4","year":"2012","unstructured":"Niemel\u00e4 M, Kauko O, Sihto H, Mpindi JP, Nicorici D, Pernil\u00e4 P, Kallioniemi OP, Joensuu H, Hautaniemi S, Westermarck J (2012) CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes. Oncogene 31:4266\u20134278","journal-title":"Oncogene"},{"key":"9709_CR28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1096\/fj.08-120550","volume":"23","author":"A Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay A, Saddoughi SA, Song P, Sultan I, Ponnusamy S, Senkal CE, Snook CF, Arnold HK, Sears RC, Hannun YA, Ogretmen B (2009) Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J 23:751\u2013763","journal-title":"FASEB J"},{"key":"9709_CR29","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1073\/pnas.1100764108","volume":"109","author":"X Zhang","year":"2012","unstructured":"Zhang X, Farrell AS, Daniel CJ, Arnold H, Scanlan C, Laraway BJ, Janghorban M, Lum L, Chen D, Troxell M, Sears R (2012) Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. Proc Natl Acad Sci U S A 109:2790\u20132795","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9709_CR30","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1038\/onc.2010.357","volume":"29","author":"KF Chen","year":"2010","unstructured":"Chen KF, Liu CY, Lin YC, Yu HC, Liu TH, Hou DR, Chen PJ, Cheng AL (2010) CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 29:6257\u20136266","journal-title":"Oncogene"},{"key":"9709_CR31","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1073\/pnas.0811267106","volume":"106","author":"S Wei","year":"2009","unstructured":"Wei S, Chen X, Rocha K, Epling-Burnette PK, Djeu JY, Liu Q, Byrd J, Sokol L, Lawrence N, Pireddu R, Dewald G, Williams A, Maciejewski J, List A (2009) A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide. Proc Natl Acad Sci U S A 106:12974\u201312979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9709_CR32","doi-asserted-by":"crossref","first-page":"e40129","DOI":"10.1371\/journal.pone.0040129","volume":"7","author":"S Abe","year":"2012","unstructured":"Abe S, Kurata M, Suzuki S, Yamamoto K, Aisaki K, Kanno J, Kitagawa M (2012) Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis. PLoS One 7:e40129","journal-title":"PLoS One"},{"key":"9709_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0165-4608(95)00191-3","volume":"86","author":"T Souza Fernandez de","year":"1996","unstructured":"de Souza Fernandez T, Silva ML, De Souza J, De Paula MT, Abdelhay E (1996) c-MYC amplification in a case of progression from MDS to AML (M2). Cancer Genet Cytogenet 86:183\u2013184","journal-title":"Cancer Genet Cytogenet"},{"key":"9709_CR34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI60818","volume":"122","author":"N Taira","year":"2012","unstructured":"Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, Yoshida K (2012) DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest 122:859\u2013872","journal-title":"J Clin Invest"},{"key":"9709_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4048\/jbc.2012.15.2.162","volume":"15","author":"M Bonito Di","year":"2012","unstructured":"Di Bonito M, Cantile M, Collina F, Scognamiglio G, Cerrone M, La Mantia E, Barbato A, Liguori G, Botti G (2012) Overexpression of cell cycle progression inhibitor geminin is associated with tumor stem-like phenotype of triple-negative breast cancer. J Breast Cancer 15:162\u2013171","journal-title":"J Breast Cancer"},{"key":"9709_CR36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12032-013-0524-9","volume":"30","author":"G Yu","year":"2013","unstructured":"Yu G, Liu G, Dong J, Jin Y (2013) Clinical implications of CIP2A protein expression in breast cancer. Med Oncol 30:524","journal-title":"Med Oncol"},{"key":"9709_CR37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjc.6602829","volume":"93","author":"A Shetty","year":"2005","unstructured":"Shetty A, Loddo M, Fanshawe T, Prevost AT, Sainsbury R, Williams GH, Stoeber K (2005) DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 93:1295\u20131300","journal-title":"Br J Cancer"},{"key":"9709_CR38","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1172\/JCI43556","volume":"120","author":"KM Shinnick","year":"2010","unstructured":"Shinnick KM, Eklund EA, McGarry TJ (2010) Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice. J Clin Invest 120:4303\u20134315","journal-title":"J Clin Invest"},{"key":"9709_CR39","doi-asserted-by":"crossref","first-page":"e53161","DOI":"10.1371\/journal.pone.0053161","volume":"8","author":"Y Ohno","year":"2013","unstructured":"Ohno Y, Yasunaga S, Janmohamed S, Ohtsubo M, Saeki K, Kurogi T, Mihara K, Iscove NN, Takihara Y (2013) Hoxa9 transduction induces hematopoietic stem and progenitor cell activity through direct down-regulation of geminin protein. PLoS One 8:e53161","journal-title":"PLoS One"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9709-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9709-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:01:44Z","timestamp":1596744104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9709"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9709-y","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,26]]}}}